Amador Bioscience is a science-driven translational and clinical research CRO with established sites in the USA, China, and Europe.
As a leading partner in biopharmaceutical research and development, Amador Bioscience offers a comprehensive range of services, including translational science, clinical pharmacology, bioanalysis and biomarkers, regulatory strategy and submissions, and clinical research adhering to global standards. We excel in formulating and executing development strategies from pre-IND to NDA/BLA/MAA submissions.
Our scientific methodologies focus on selecting the right target, right patient, and right dose. Our global adoption of rigorous quality standards significantly enhances the efficiency and success rate of novel drug development endeavors.